Prime Medicine, Inc.
PRMENASDAQHealthcare● Active
$2.98
$-0.08(-2.61%)
Market Cap$538240001
P/E Ratio—
52W High$6.94
52W Low$1.305
Prime Medicine, Inc. (PRME) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PRME · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.63M | $2.98M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $7.32M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | ($2.69M) | $2.98M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | -58.05% | 100.00% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $160.64M | $155.29M | $147.91M | $86.72M | $70.55M |
| G&A Expenses | $52.35M | $50.16M | $43.39M | $29.82M | $13.92M |
| Total Operating Expenses | $205.66M | $205.45M | $204.79M | $116.54M | $84.47M |
| Operating Income | ($208.35M) | ($202.47M) | ($204.79M) | ($116.54M) | ($84.47M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $4.15M | $3.52M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($201.14M) | ($195.88M) | ($198.41M) | ($122.77M) | ($165.85M) |
| Income Tax Expense | $0.00M | $0.00M | ($0.28M) | ($0.95M) | ($0.49M) |
| Net Income | ($201.14M) | ($195.88M) | ($198.13M) | ($121.82M) | ($165.37M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.35 | $-1.65 | $-2.18 | $-1.46 | $-1.92 |
| Wtd Avg Shares | 148.76M | 118.60M | 90.97M | 97.21M | 95.73M |
| EBITDA | ($195.76M) | ($196.34M) | ($186.64M) | ($114.32M) | ($83.91M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Prime Medicine, Inc. data
About Prime Medicine, Inc. (PRME) Income Statement
Prime Medicine, Inc. (PRME) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PRME reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -58.05%), and net income of ($0.20B) — a net profit margin of -4342.44%.
Frequently asked questions
PRME · 4 questionsPrime Medicine, Inc. (PRME) reported revenue of $0.00B for 2025, up 55.3% year-over-year.
PRME revenuePRME salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08